UK clinical
research update

October 2026 edition

Published November 5, 2026

This monthly update summarises recent news, announcements, guidance, and updates on progress made to propel the aims of the UK Clinical Research Delivery programme of work. This update provides examples of how organisations individually and collaboratively are achieving the collective goal of making the UK a world leader in clinical trials.

Table of Contents

Highlights

Landmark moment for UK clinical research as commercial trial set-up times fall to 100 days

Setting up clinical trials faster really matters because it means life-changing health and care research reaches the right people and places sooner. Through collective action across the UKCRD programme, the UK has delivered on the landmark target set out in the Life Sciences Sector Plan to reduce commercial interventional trial set-up times to under 150 days by March 2026.

Key highlights:

  • 100% of commercial pharmaceutical studies starting set-up in 2025/26 Q4 met the national target.
  • Average commercial pharmaceutical trial set-up times dropped to 100 days, down from 153 days during the same period in 2024/25.
  • Delivered by eliminating administrative duplication, replacing repeated local trust renegotiations with a single national tariff process for costing and contracting (NCVR), streamlining regulatory approvals and the dedicated efforts of health and research professionals across the healthcare systems of the UK.
  • Our focus now moves to stronger recruitment and reliable whole-study delivery, working towards our national ambition to quadruple commercial interventional trial participants by 2029.
  • Read the full announcement in the Department of Health and Social Care press release on GOV.UK and find a summary on the UKCRD website.

Related articles from our partners: HRA, AMRC, NIHR, NHS Research Scotland

UK Clinical Research Delivery Performance Indicators Report

Read the latest monthly UKCRD key performance indicators (KPIs) report which brings together data from the NIHR and the Medicines and Healthcare products Regulatory Agency (MHRA) to monitor the delivery of globally competitive clinical research across the UK. It is produced by DHSC on behalf of the UK research delivery system each month. The report provides transparent updates on progress towards our goals over time.

Recognition of High-performing NHS Trusts in Clinical Trial Delivery

The UKCRD programme highlights NHS trusts with strong commercial interventional study-set up performance. This is defined as having delivered at least 95% of studies on target over the previous 6 months or, for Trusts that completed 10 or more studies in the past 12 months, having delivered at least 9 of the last 10 studies on target.

NHS trusts achieving a Global or European First are also highlighted, reflecting rapid and responsive trial set up.

We will continue to review and may iterate the criteria used to highlight Trusts each month, to ensure strong study set-up performance across different kinds of Trusts is being recognised.

Trusts completing set-up for 95% of commercial interventional trials within 90 days (following approval or site selection; studies on NIHR RDN portfolio)

Trust, Location% studies set up within 90 days of approval or site selectionNumber of studies set up within 90 days / Total studies
University Hospitals Sussex NHS Foundation Trust100%6/6
Midlands Partnership University NHS Foundation Trust100%4/4
Northumbria Healthcare NHS Foundation Trust100%3/3

Trusts completing set up for ≥90% of their 10 most recent commercial interventional trials within 90 days (following approval or site selection; studies on NIHR RDN portfolio; for Trusts completing 10 or more in the past 12 months)

Trust, Location% studies set up within 90 days of approval or site selectionNumber of studies set up within 90 days / Total studies
The Royal Marsden NHS Foundation Trust90%9/10
Cambridge University Hospitals NHS Foundation Trust90%9/10
Guy's and St Thomas' NHS Foundation Trust90%9/10
University Hospitals Sussex NHS Foundation Trust90%9/10

Trusts achieving a Global or European First in March – September 2026 (Studies on the NIHR RDN portfolio)

First Recruitment TypeDate Achieved (FPFV)Therapeutic AreaRecruiting Organisation, Location
Global01/09/2026RenalNinewells Hospital, Tayside Health Board, Dundee, Angus
Global24/09/2026Cancer (haematological oncology)Hammersmith Hospital, Imperial College Healthcare NHS Trust
European29/09/2026Cancer (gynaecological)University College Hospital, University College London Hospitals NHS Foundation Trust
Global24/08/2026Diabetes, Metabolic and EndocrineHull Royal Infirmary, Hull University Teaching Hospitals NHS Trust
European06/08/2026Diabetes, Metabolic and EndocrineLeicester General Hospital, University Hospitals of Leicester NHS Trust
European05/08/2026Cancer (haematology)Hammersmith Hospital, Imperial College Healthcare NHS Trust
European05/08/2026Infection (paediatric)St Mary's Hospital (HQ), Imperial College Healthcare NHS Trust
European31/07/2026HaematologyCentral Middlesex Hospital, London North West University Healthcare NHS Trust
European30/07/2026RespiratoryCastle Hill Hospital, Hull University Teaching Hospitals NHS Trust
European28/07/2026Cancer (colorectal)The Royal Marsden Hospital (Surrey), The Royal Marsden NHS Foundation Trust
*European27/08/2026Cancer (upper gastrointestinal)The Royal Marsden Hospital (Surrey), The Royal Marsden NHS Foundation Trust
*Global14/08/2026Mental HealthWoodstock Bower Group Practice
European13/08/2026Cancer (prostate)The Royal Marsden Hospital (Surrey), The Royal Marsden NHS Foundation Trust
European15/07/2026Musculoskeletal and OrthopaedicsWestern General Hospital, Lothian Health Board, Scotland
European14/07/2026Cancer (colorectal)The Royal Marsden Hospital (Surrey), The Royal Marsden NHS Foundation Trust
European08/07/2026Cancer (upper gastroi-intestinal)Churchill Hospital, Oxford University Hospitals NHS Foundation Trust
European07/07/2026Cancer (gynaecological)The Royal Marsden Hospital (Surrey), The Royal Marsden NHS Foundation Trust
Global06/07/2026Diabetes, Metabolic and EndocrineLayton Medical Centre
*European06/07/2026Cancer (haematological oncology)The Christie, The Christie NHS Foundation Trust
*Global30/06/2026Cancer (brain)Clatterbridge Cancer Centre - Wirral, The Clatterbridge Cancer Centre NHS Foundation Trust
Global29/06/2026Diabetes, Metabolic and EndocrineLeicester General Hospital, University Hospitals of Leicester NHS Trust
Global23/06/2026HaematologyThe Royal London Hospital, Barts Health NHS Trust
European23/06/2026RespiratoryBradford Royal Infirmary, Bradford Teaching Hospitals NHS Foundation Trust
European23/06/2026Cancer (haematology)Royal Marsden Hospital (Surrey), The Royal Marsden NHS Foundation Trust
European22/06/2026Gastroenterology and HepatologyKing's College Hospital (Denmark Hill), King's College Hospital NHS Foundation Trust
European15/06/2026Diabetes, Metabolic and EndocrineLeicester General Hospital, University Hospitals of Leicester NHS Trust
European10/06/2026RespiratoryPerth Royal Infirmary, Tayside Health Board
European10/06/2026RespiratoryNorfolk & Norwich University Hospital, Norfolk and Norwich University Hospitals NHS Foundation Trust
European08/06/2026Infection (paediatric)University College Hospital, University College London Hospitals NHS Foundation Trust
European08/06/2026Dementia and NeurodegenerationUniversity College Hospital, University College London Hospitals NHS Foundation Trust
Global02/06/2026Gastroenterology and HepatologyUniversity College Hospital, University College London Hospitals NHS Foundation Trust
Global02/06/2026Reproductive Health and ChildbirthBradford Royal Infirmary, Bradford Teaching Hospitals NHS Foundation Trust
Global28/05/2026Diabetes, Metabolic & EndocrineBristol Royal Infirmary, University Hospitals Bristol and Weston NHS Foundation Trust
Global27/05/2026Cancer (haematological oncology)King's College Hospital (Denmark Hill), King's College Hospital NHS Foundation Trust
European19/05/2026Children (Gastroenterology and Hepatology)Sheffield Children's Hospital, Sheffield Children's NHS Foundation Trust
*European14/05/2026Children (ear, nose and throat / surgery)Great Ormond Street Hospital Central London Site, Great Ormond Street Hospital for Children NHS Foundation Trust
European12/05/2026Cancer (lung)Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust
Global08/05/2026CardiovascularBasildon Hospital, Mid and South Essex NHS Foundation Trust
European07/05/2026Haematology (children)Hammersmith Hospital, Imperial College Healthcare NHS Trust
European06/05/2026Musculoskeletal
& Orthopaedics
Peterborough City Hospital, North West Anglia NHS Foundation Trust
European05/05/2026Cancer (prostate)Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust
Global04/05/2026Cancer (gynaecological, head and neck, lung)The Christie, The Christie NHS Foundation Trust
European29/04/2026OpthalmologyCentral Middlesex Hospital, London North West University Healthcare NHS Trust
*European28/04/2026RenalFreeman Hospital, The Newcastle Upon Tyne Hospitals NHS Foundation Trust
European27/04/2026Cancer (prostate)Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust
Global24/04/2026Cancer (haematological
oncology)
Hammersmith Hospital, Imperial College Healthcare NHS Trust
European22/04/2026Gastroenterology and HepatologyClinical Research Facility, University Hospitals Bristol And Weston NHS Foundation Trust
European21/04/2026Diabetes, Metabolic and EndocrineStaploe Medical Centre, Ely, Cambridgeshire
Global21/04/2026Diabetes, Metabolic & EndocrineStaploe Medical Centre, Ely, Cambridgeshire
European16/04/2026Cancer (bladder)The Christie, The Christie NHS Foundation Trust
European16/04/2026CardiovascularSt Bartholomew's Hospital, Barts Health NHS Trust
Global10/04/2026Musculoskeletal
& Orthopaedics
The Royal Victoria Infirmary, The Newcastle-Upon-Tyne Hospitals NHS Foundation Trust
European08/04/2026DermatologyChelsea and Westminster Hospital, Chelsea and Westminster Hospital NHS Foundation Trust
European07/04/2026Surgery (orthopaedic)Hinchingbrooke Hospital, North West Anglia NHS Foundation Trust
European02/04/2026Cancer (renal)The Royal Marsden Hospital (London), The Royal Marsden NHS Foundation Trust
European31/03/2026Gastroenterology and HepatologyWoodstock Bower Group Practice
European31/03/2026Gastroenterology and HepatologyWoodstock Bower Group Practice
European31/03/2026Mental HealthWoodstock Bower Group Practice, Rotherham, South Yorkshire
Global30/03/2026RenalSouthmead Hospital, North Bristol NHS Trust
European26/03/2026Musculoskeletal
& Orthopaedics
The Royal Victoria Infirmary, The Newcastle-Upon-Tyne Hospitals NHS Foundation Trust
European06/03/2026Cancer (head & neck)The Royal Marsden Hospital (Surrey), The Royal Marsden NHS Foundation Trust
European05/03/2026DermatologySalford Royal Hospital, Northern Care Alliance NHS Foundation Trust
European05/03/2026Cancer (haematological oncology)Gloucestershire Royal Hospital, Gloucestershire Hospitals NHS Foundation Trust
European04/03/2026Cancer (breast)Royal Sussex County Hospital, University Hospitals Sussex NHS Foundation Trust
European03/03/2026Cancer (prostate)The Royal Marsden Hospital (Surrey), The Royal Marsden NHS Foundation Trust

* denotes retrospectively reported Global and European Firsts

35 Global Firsts and 72 European Firsts were achieved in England in 2025/26, and one Global and four European Firsts in the Devolved Administrations. A full list of previous Firsts and further detail on the parameters can be found here: Global and European Firsts.

Trust-level set-up performance data, including new supplementary data tables are published monthly here: UKCRD.org.

Trust level recruitment reports with data on recruitment activity for commercial interventional trials at each NHS trust over the preceding six months are published monthly here: UKCRD.org

Study set up acceleration activities:

Please email a brief overview of any current or upcoming projects that accelerate clinical trial set-up times to ukcrdprogramme@dhsc.gov.uk so we can coordinate activities and map opportunities.

News and Announcements

The following updates are from our dedicated partners across the sector.

  • NHSE: New FAQs have been developed in response to queries about the NHS Oversight Framework (NOF) Research Indicator. The Research Indicator has been introduced to provide a consistent national measure of research activity and study set-up performance across NHS providers. Read the FAQs on the UKCRD website.
  • ABPI: published its annual clinical trials report which provides an assessment of where positive progress has been made, where performance remains off-track, and the changing international competition influencing trial placement.
  • MHRA: The Government response to the National Commission into the Regulation of AI in Healthcare is now live, accepting all 44 recommendations and setting out the next steps for delivery across the UK. Read about the next steps. 
  • MHRA: launched a new Real-World Evidence (RWE) Knowledge and Guidance Hub which brings together guidance, publications and supporting resources making it easier for organisations, researchers and developers to navigate the regulatory use of real-world data and evidence.
  • MHRA’s final strategy blog reflects on the insights shared by experts across the UK, and how collaboration, innovation and patient safety are shaping the future of healthcare regulation. The strategy blogs have supported the development of MHRA’s new strategy to 2030 by discussing various challenges and opportunities ahead. Read responses to the new strategy from: ABPI, HRA and find explainers for the strategy here.
  • MHRA: It has been 6 months since the UK’s new clinical trial regulations came into force, introducing a more flexible and risk-proportionate approach to clinical trial assessment. The MHRA has published a blog reflecting on the implementation of the regulations with practical insights to support a more efficient assessment process.
  • ABPI: has published a new vision for health and growth in Northern Ireland which calls for investment in clinical research, trusted use of health data, and strengthening partnerships to help make Northern Ireland a beacon for access to health innovations. Read the full report and recommendations. 
  • ABPI: shared a new blog on how Scotland can turn research into better care for patients highlighting that strong research and industry clinical trials give patients early access to treatments while bringing vital resources and expertise into the NHS. A health service ready to adopt innovations keeps the population healthier and makes Scotland an attractive hub for future studies.
  • An NIHR blog from CEO Professor Lucy Chappell and Life Sciences Industry Director Dr Maria Koufali exploring how UK research brings together scientific expertise, industry and the NHS to improve lives and support growth.
  • Singapore Healthtech Bilateral Partnership: The NIHR and the National Health Innovation Centre Singapore (NHIC) have partnered to fast-track healthcare innovations across the UK and Singapore that address unmet, shared clinical needs. Read the full story.
  • NIHR is starting work on its Strategic Plan for Inclusion, covering 2028 to 2033. Good science is inclusive, and NIHR knows just how important it is that a plan like this isn’t designed in a silo, so they’re inviting you to take part by volunteering your time to complete a short survey. 

Recent success stories

  • NIHR: Beatrix: Group B Strep mums call on pregnant women to join vaccine trial giving hope to future parents
    The UK has launched the world’s first large-scale Phase 3 maternal vaccine trial (BEATRIX) for group B streptococcus (GBS), the leading cause of newborn sepsis and meningitis. Supported by the NIHR across 10 NHS sites and sponsored by Pfizer, the trial evaluates an investigational vaccine to prevent avoidable infant deaths, stillbirths, and lifelong disabilities, while actively driving recruitment diversity across disproportionately affected Black and Asian communities. Read the full story.
  • AD-SMART is a first-of-its-kind trial for the UK which could halve the time it takes to test Alzheimer’s treatments.
    AD-SMART is funded by the UK Dementia Research Institute (UK DRI), Alzheimer’s Research UK (ARUK) in partnership with the NIHR, the Medical Research Council (MRC) and Health Data Research UK (HDR UK). Ongoing funding has been committed by the UK government to support the trial. The trial will initially examine whether two repurposed medicines already used to treat type 2 diabetes and attention deficit hyperactivity disorder (ADHD) can lessen symptoms such as memory and thinking problems, and help people maintain their quality-of-life as the disease progresses. Read the full story.
  • Strengthening research delivery in primary and community care across Wales
    Health and Care Research Wales’ Primary and Community Care Research Delivery Network  (PCCRDN) is helping to make research possible in settings including general practices, pharmacies, dental practices and optometry. The Network provides practical support to build research capacity and widen opportunities for people to take part in research closer to home. In the ThinkCancer! study, which aims to improve cancer diagnosis in the community, the network’s research nurses supported 21 practices across Wales helping them remain engaged and accelerating data collection at scale. Read the full story. 
  • CRDC: Cheshire and Merseyside pioneers innovative IMP transfer model to bring research closer to patients
    The NIHR Commercial Research Delivery Centre in Primary Care (CRDC-PC): Cheshire and Merseyside has successfully developed an innovative approach to Investigational Medicinal Product (IMP) transfer between sites, with scope to scale across the UK. The approach enables participants to take part in research closer to home while supporting recruitment across a wider geographical area. Read the full story. 
  • Expanding routes into clinical research across Northern Ireland
    The Western Health and Social Care Trust has launched Northern Ireland’s first Mobile Health Research Service, the specially designed mobile unit takes clinical trials out of traditional hospital settings and into rural, socioeconomically deprived and underserved communities broadening trial participation and building trust across the region. The Southern Health and Social Care Trust has also officially opened its new Commercial Research Delivery Centre (CRDC) at Craigavon Area Hospital. This is the Trust’s first dedicated facility for commercial clinical research and will give more people the opportunity to take part in research and access innovative treatments. Read about how the contributions of service users, carers and staff have helped shape the identity and environment of the new CRDC through collaborative artwork. 
  • Building a Scalable Shared Care Model to Deliver Complex Advanced Therapy Clinical Trials
    The Advanced Therapy Treatment Centre (ATTC) network released a new case study demonstrating how iMATCH partners, Northern Care Alliance NHS Foundation Trust, and Manchester University NHS Foundation Trust developed a shared care model to deliver a CAR T-cell autoimmune trial across two organisations. Together, through collaboration with relevant partners across the breadth of the ATTC network, they worked to develop UK wide shared care guidance. Read the full case study. 

 

Read more about how UKCRD efforts are helping to make the UK a world leader in clinical trials​ on the UKCRD news page.

If you would like to submit a success story or update to this monthly publication, please email ukcrdprogramme@dhsc.gov.uk